Emergent BioSolutions (EBS) Treasury Shares (2011 - 2026)

Emergent BioSolutions' Treasury Shares history runs 15 years deep, the most recent figure standing at $261.6 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 14.89% year-over-year to $261.6 million; the TTM figure through Mar 2026 stood at $261.6 million (up 14.89% YoY), while the FY2025 annual figure was $252.6 million, up 10.94% from the prior year.
• Treasury Shares was $261.6 million for Q1 2026 at Emergent BioSolutions, up from $252.6 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $8.7 million in Q4 2025 to a low of $900000.0 in Q1 2026.
• Historically, Treasury Shares has averaged $5.7 million across 5 years, with a median of $5.6 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares soared 475.0% in 2022, then changed 0.0% in 2023.
• A 5-year view of Treasury Shares shows it stood at $227.7 million in 2022, then changed by 0.0% to $227.7 million in 2023, then changed by 0.0% to $227.7 million in 2024, then advanced by 10.94% to $252.6 million in 2025, then grew by 3.56% to $261.6 million in 2026.
• The last three Treasury Shares figures came in at $261.6 million (Q1 2026), $252.6 million (Q4 2025), and $243.5 million (Q3 2025), per Business Quant data.